Patent · US Active

8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals

US8106060B2 · kind B2 · utility

67Cited by

78References

21Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Waldemar Pfrengle · Seibersbach, DE
Peter Sieger · Mittelbiberach, DE

Key dates

Filing date	Jul 30, 2006
Grant date	Jan 31, 2012
Priority date	—
Expiry date	Aug 11, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to 8-[3-amino-piperidin-1-yl]-xanthines and the physiologically acceptable salts thereof, particularly the hydrochlorides thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.